Form 8-K Aravive, Inc. For: Nov 20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Aravive Inc. (ARAV) PT Raised to $31 at H.C. Wainwright
November 20, 2019 12:14 PM ESTH.C. Wainwright analyst Joseph Pantginis raised the price target on Aravive Inc. (NASDAQ: ARAV) to $31.00 (from $18.00) while maintaining a Buy rating.
The analyst commented, "This morning, Aravive announced new positive data from the ongoing Phase 1b portion of the Phase 1b/2 clinical trial of... More
Aravive Inc. (ARAV) Halted on LUDP
November 20, 2019 9:46 AM ESTAravive Inc. (NASDAQ: ARAV) Halted on LUDP
... MoreAravive Inc. (ARAV) Extends Gain, Up 250%
November 20, 2019 7:43 AM ESTAravive Inc. (NASDAQ: ARAV) Extends Gain, Up 250%
